92 related articles for article (PubMed ID: 23548582)
1. Blockage of peripheral NPY Y1 and Y2 receptors modulates barorefex sensitivity of diabetic rats.
Liu J; Wang N; Xie F; Sun LH; Chen QX; Ye JH; Cai BZ; Yang BF; Ai J
Cell Physiol Biochem; 2013; 31(2-3):421-31. PubMed ID: 23548582
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of peripheral NPY Y1 and Y2 receptors ameliorates the aberrant baroreceptor reflex sensitivity in streptozotocin induced diabetic rats.
Niu HF; Xu L; Yan Y; Xie F; Yang BF; Ai J
Sheng Li Xue Bao; 2013 Aug; 65(4):370-80. PubMed ID: 23963068
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y reverses chronic stress-induced baroreflex hypersensitivity in rats.
Xie F; Sun L; Su X; Wang Y; Liu J; Zhang R; Wang N; Zhao J; Ban T; Niu H; Ai J
Cell Physiol Biochem; 2012; 29(3-4):463-74. PubMed ID: 22508053
[TBL] [Abstract][Full Text] [Related]
4. Does the neuropeptide Y Y1 receptor contribute to blood pressure control in the spontaneously hypertensive rat?
Zhao XH; Sun XY; Edvinsson L; Hedner T
J Hypertens; 1997 Jan; 15(1):19-27. PubMed ID: 9050966
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of the daming capsule on impaired baroreflexes in STZ-induced diabetic rats with hyperlipoidemia.
Ai J; Wang LH; Zhang R; Qiao GF; Wang N; Sun LH; Lu GY; Sun C; Yang BF
BMC Complement Altern Med; 2010 Dec; 10():80. PubMed ID: 21176164
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y-mediated sex- and afferent-specific neurotransmissions contribute to sexual dimorphism of baroreflex afferent function.
Liu Y; Wu D; Qu MY; He JL; Yuan M; Zhao M; Wang JX; He J; Wang LQ; Guo XJ; Zuo M; Zhao SY; Ma MN; Li JN; Shou W; Qiao GF; Li BY
Oncotarget; 2016 Oct; 7(40):66135-66148. PubMed ID: 27623075
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y and glutamatergic mechanisms in the amygdala and ventral hippocampus differentially mediate impaired social behavior in diabetic mice.
Ueda D; Yonemochi N; Kamata T; Kamei J; Waddington JL; Ikeda H
Behav Brain Res; 2021 May; 405():113195. PubMed ID: 33617904
[TBL] [Abstract][Full Text] [Related]
8. Long-term neuropeptide Y administration in the periphery induces abnormal baroreflex sensitivity and obesity in rats.
Xie F; Zhang R; Yang C; Xu Y; Wang N; Sun L; Liu J; Sun L; Wei R; Ai J
Cell Physiol Biochem; 2012; 29(1-2):111-20. PubMed ID: 22415080
[TBL] [Abstract][Full Text] [Related]
9. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
Wieland HA; Willim KD; Entzeroth M; Wienen W; Rudolf K; Eberlein W; Engel W; Doods HN
J Pharmacol Exp Ther; 1995 Oct; 275(1):143-9. PubMed ID: 7562543
[TBL] [Abstract][Full Text] [Related]
10. Expression of neuropeptide Y and its receptors Y1 and Y2 in the rat heart and its supplying autonomic and spinal sensory ganglia in experimentally induced diabetes.
Chottová Dvoráková M; Wiegand S; Pesta M; Slavíková J; Grau V; Reischig J; Kuncová J; Kummer W
Neuroscience; 2008 Feb; 151(4):1016-28. PubMed ID: 18201831
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors.
Schwertfeger E; Klein T; Vonend O; Oberhauser V; Stegbauer J; Rump LC
Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):455-61. PubMed ID: 15103451
[TBL] [Abstract][Full Text] [Related]
12. Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock.
Qureshi NU; Dayao EK; Shirali S; Zukowska-Grojec Z; Hauser GJ
Regul Pept; 1998 Sep; 75-76():215-20. PubMed ID: 9802412
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
Doods HN; Wienen W; Entzeroth M; Rudolf K; Eberlein W; Engel W; Wieland HA
J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541
[TBL] [Abstract][Full Text] [Related]
14. The protective effect of Daming capsule on heart function in streptozocin-induced diabetic rats with hyperlipidemia.
Ai J; Yan X; Zhao L; Lu Y; Liang F; Cai B; Li G; Lu Y; Yang B
Biol Pharm Bull; 2009 Aug; 32(8):1354-8. PubMed ID: 19652373
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle.
Misra S; Mahavadi S; Grider JR; Murthy KS
Regul Pept; 2005 Feb; 125(1-3):163-72. PubMed ID: 15582728
[TBL] [Abstract][Full Text] [Related]
16. Lateral septal infusions of the neuropeptide Y Y2 receptor agonist, NPY(13-36) differentially affect different defensive behaviors in male, Long Evans rats.
Trent NL; Menard JL
Physiol Behav; 2013 Feb; 110-111():20-9. PubMed ID: 23274501
[TBL] [Abstract][Full Text] [Related]
17. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
Modin A; Malmström RE; Meister B
Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.
Sautel M; Rudolf K; Wittneben H; Herzog H; Martinez R; Munoz M; Eberlein W; Engel W; Walker P; Beck-Sickinger AG
Mol Pharmacol; 1996 Aug; 50(2):285-92. PubMed ID: 8700135
[TBL] [Abstract][Full Text] [Related]
19. The involvement of neuropeptide Y Y1 receptors in the blood pressure baroreflex: studies with BIBP 3226 and BIBO 3304.
Capurro D; Huidobro-Toro JP
Eur J Pharmacol; 1999 Jul; 376(3):251-5. PubMed ID: 10448884
[TBL] [Abstract][Full Text] [Related]
20. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
Malmström RE; Balmér KC; Lundberg JM
Br J Pharmacol; 1997 Jun; 121(3):595-603. PubMed ID: 9179405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
